Product Details for: Opdivo Qvantig

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
600MG/5ML;10,000UNITS/5ML (120MG/2,000UNITS/ML)
Single-Dose Vial
351(a)
Opdivo Qvantig
Rx
002
Injection
Subcutaneous
300MG/2.5ML;5,000UNITS/2.5ML (120MG/2,000UNITS/ML)
Single-Dose Vial
351(a)
Opdivo Qvantig
Rx
Proper Name
nivolumab and hyaluronidase-nvhy
BLA Number
761381
Applicant
Bristol-Myers Squibb Company
Original Approval Date
December 27, 2024
Date of First Licensure
RETURN TO SEARCH RESULTS